- Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled studyJohn D Lloyd-Still
Rush University Medical Center, Chicago, Illinois, USA
Nutrition 22:36-46. 2006..The study objective was to determine bioavailability, tissue accretion, and safety of a large dose of an algal source of docosahexaenoic acid (DHA) triacylglycerol and to observe effects on lung function in patients with CF...
- Essential fatty acid deficiency and nutritional supplementation in cystic fibrosisJohn D Lloyd-Still
J Pediatr 141:157-9. 2002